Skip to main content
OpenTrials

Clinical trial condition

Heterozygous Familial Hypercholesterolemia

Explore clinical trials studying Heterozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

26 public trials 3 recruiting studies

Heterozygous Familial Hypercholesterolemia trial results

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +18 more
Locations
  • Clinical Study Center Dothan, Alabama, United States
  • Clinical Study Center Pomona, California, United States
  • Clinical Study Center Boca Raton, Florida, United States
  • Clinical Study Center Jacksonville, Florida, United States
View all 24 locations
Conditions
ASCVD, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations
  • Beijing Anzhen Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Luhe Hospital, Capital Medical Univeristy Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgeng Hospital Beijing, Beijing Municipality, China
  • Fuwai Hospital, CAMS & PUMC Beijing, Beijing Municipality, China
View all 18 locations
Conditions
Dyslipidemias, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia, +4 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Matsudo, Chiba, Japan
  • Novartis Investigative Site Itoshima, Fukuoka, Japan
  • Novartis Investigative Site Kitakyushu, Fukuoka, Japan
View all 42 locations